Hiroshi Hayashi, Kazuhiro Uda, Keiji Akamine, Nanako Kawata, Shogo Akahoshi, Masaki Shimizu, Yuho Horikoshi, Hiroshi Hataya,
Pediatr Infect Dis J (The Pediatric infectious disease journal)
[2021, 40(2):173-174]
Cited: 0 times
Kazuki Iio, Naoya Fukushima, Keiji Akamine, Kazuhiro Uda, Hiroshi Hataya, Masaru Miura,
Kawasaki disease and acute rheumatic fever are two major causes of acquired heart disease in the pediatric population. Although both conditions are well-known entities, the association between them has never been described. We report herein a case of 6-year-old male patient who first presented with Kawasaki shock syndrome, followed by ... Read more >>
Front Pediatr (Frontiers in pediatrics)
[2020, 8:562]
Cited: 0 times
Kazuki Iio, Naoya Fukushima, Keiji Akamine, Kazuhiro Uda, Hiroshi Hataya, Masaru Miura,
Kawasaki disease and acute rheumatic fever are two major causes of acquired heart disease in the pediatric population. Although both conditions are well-known entities, the association between them has never been described. We report herein a case of 6-year-old male patient who first presented with Kawasaki shock syndrome, followed by ... Read more >>
Front Pediatr (Frontiers in pediatrics)
[2020, 8:]
Cited: 0 times
Keiji Akamine, Marilynn Punaro,
Recent advances have allowed better understanding of vasculitis pathogenesis and led to more targeted therapies. Two pivotal randomized controlled trials, RITUXVAS and rituximab in ANCA-associated vasculitis (RAVE), provide high-quality evidence demonstrating rituximab (RTX) is efficacious in inducing remission in adult ANCA-associated vasculitis (AAV) patients compared with cyclophosphamide (CYC). RAVE also ... Read more >>
Pediatr Nephrol (Pediatric nephrology (Berlin, Germany))
[2019, 34(11):2295-2309]
Cited: 1 time